Towards standardization of immune functional assays.


Journal

Clinical immunology (Orlando, Fla.)
ISSN: 1521-7035
Titre abrégé: Clin Immunol
Pays: United States
ID NLM: 100883537

Informations de publication

Date de publication:
01 2020
Historique:
received: 29 07 2019
revised: 16 10 2019
accepted: 18 11 2019
pubmed: 25 11 2019
medline: 1 8 2020
entrez: 25 11 2019
Statut: ppublish

Résumé

Recent advances in the immunotherapy field require evaluation of the immune function to adapt therapeutic decisions. Immune functional assays (IFA) are able to reveal the immune status and would be useful to further adapt and/or improve patient's care. However, standardized methods are needed to implement IFA in clinical settings. We carried out an independent validation of a published method used to characterize the underlying host response to infectious conditions using an IFA. We evaluated the reproducibility and robustness of this IFA and the associated readout using an independent healthy volunteers (HV) cohort. Expression of a 44-gene signature and IFNγ protein secretion was assessed after stimulation. We observed a strong host-response correlation between the two cohorts. We also highlight that standardized methods for immune function evaluation exist and could be implemented in larger-scale studies. This IFA could be a relevant tool to reveal innate and adaptive immune dysfunction in immune-related disorders patients.

Identifiants

pubmed: 31760096
pii: S1521-6616(19)30405-X
doi: 10.1016/j.clim.2019.108312
pii:
doi:

Substances chimiques

Interferon-gamma 82115-62-6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108312

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest William Mouton, Chloé Albert Vega, Guy Oriol, Alexandre Pachot, Julien Textoris, François Mallet and Karen Brengel-Pesce, are employed at bioMérieux, an in-vitro diagnostic company. François Bartolo is an employee of Soladis, a services company specialized in data-related projects management.

Auteurs

William Mouton (W)

Joint Research Unit Hospices Civils de Lyon-bioMérieux, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France; Open Innovation & Partnerships (OIP), bioMérieux S.A., Marcy l'Etoile, France; Virologie et Pathologie Humaine - Virpath Team, Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, CNRS UMR5308, ENS Lyon, Claude Bernard Lyon 1 University, Lyon, France. Electronic address: william.mouton1@biomerieux.com.

Chloé Albert-Vega (C)

Joint Research Unit Hospices Civils de Lyon-bioMérieux, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France; Open Innovation & Partnerships (OIP), bioMérieux S.A., Marcy l'Etoile, France.

Mathilde Boccard (M)

Joint Research Unit Hospices Civils de Lyon-bioMérieux, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.

François Bartolo (F)

Joint Research Unit Hospices Civils de Lyon-bioMérieux, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France; Soladis, Lyon, France.

Guy Oriol (G)

Joint Research Unit Hospices Civils de Lyon-bioMérieux, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France; Open Innovation & Partnerships (OIP), bioMérieux S.A., Marcy l'Etoile, France.

Jonathan Lopez (J)

Hospices Civils de Lyon, Plateforme de Recherche de Transfert en Oncologie, Department of Biochemistry and Molecular biology, Lyon Sud Hospital, Pierre-Bénite, France.; Université de Lyon, Claude Bernard Lyon 1 University, Faculté de Médecine Lyon Est, Lyon, France.; Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS UMR5286, Lyon, France.

Alexandre Pachot (A)

Open Innovation & Partnerships (OIP), bioMérieux S.A., Marcy l'Etoile, France.

Julien Textoris (J)

Joint Research Unit Hospices Civils de Lyon-bioMérieux, EA 7426 Pathophysiology of Injury-Induced Immunosuppression, PI3, Claude Bernard Lyon 1 University, Edouard Herriot Hospital, Lyon, France.; Hospices Civils de Lyon, Department of Anesthesia and Critical Care Medicine, Edouard Herriot Hospital, Lyon, France.

François Mallet (F)

Joint Research Unit Hospices Civils de Lyon-bioMérieux, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France; Open Innovation & Partnerships (OIP), bioMérieux S.A., Marcy l'Etoile, France; Joint Research Unit Hospices Civils de Lyon-bioMérieux, EA 7426 Pathophysiology of Injury-Induced Immunosuppression, PI3, Claude Bernard Lyon 1 University, Edouard Herriot Hospital, Lyon, France.

Karen Brengel-Pesce (K)

Joint Research Unit Hospices Civils de Lyon-bioMérieux, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France; Open Innovation & Partnerships (OIP), bioMérieux S.A., Marcy l'Etoile, France.

Sophie Trouillet-Assant (S)

Joint Research Unit Hospices Civils de Lyon-bioMérieux, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France; Virologie et Pathologie Humaine - Virpath Team, Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, CNRS UMR5308, ENS Lyon, Claude Bernard Lyon 1 University, Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH